Search

Author/Creator Necchi, A

12. 920TiPErdafitinib compared with vinflunine or docetaxel or pembrolizumab in patients (pts) with metastatic or surgically unresectable (M/UR) urothelial carcinoma (UC) and selected fgfr gene alterations (FGFRalt): The phase III THOR study. (23rd October 2018)

Authors:
Loriot, Y; Necchi, A; Park, S H; Huddart, R A; Burgess, E; Zhong, B; Santiago-Walker, A; Little, S; Roccia, T; De Porre, P; Siefker-Radtke, A O
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. 923TiPA phase III study of INCB054828 as adjuvant therapy in patients (pts) with high-risk urothelial carcinoma (UC) harboring fibroblast growth factor receptor 3 (FGFR3) genomic alterations. (23rd October 2018)

Authors:
Necchi, A; Pérez-Gracia, J L; Loriot, Y; Witjes, W; Montorsi, F; Bjartell, A; Shariat, S F
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. 928TiPATLAS: A phase II, open-label study of rucaparib in patients (pts) with locally advanced (unresectable) or metastatic urothelial carcinoma. (23rd October 2018)

Authors:
Chowdhury, S; Feyerabend, S; Loriot, Y; Necchi, A; Gupta, S; Josephs, D H; Rodríguez-Vida, A; Srinivas, S; Zakharia, Y; Nepert, D; Wride, K; Thomas, D; Loehr, A; Simmons, A D; Grivas, P
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. (19th November 2019)

Authors:
Horwich, A; Babjuk, M; Bellmunt, J; Bruins, H M; Reijke, T M De; Santis, M De; Gillessen, S; James, N; Maclennan, S; Palou, J; Powles, T; Ribal, M J; Shariat, S F; Kwast, T Van Der; Xylinas, E; Agarwal, N; Arends, T; Bamias, A; Birtle, A; Black, P C
Journal:
Annals of oncology
Issue:
Volume 30:Number 11(2019)
Page Start:
1697
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. (3rd August 2018)

Authors:
Honecker, F; Aparicio, J; Berney, D; Beyer, J; Bokemeyer, C; Cathomas, R; Clarke, N; Cohn-Cedermark, G; Daugaard, G; Dieckmann, K -P; Fizazi, K; Fosså, S; Germa-Lluch, J R; Giannatempo, P; Gietema, J A; Gillessen, S; Haugnes, H S; Heidenreich, A; Hemminki, K; Huddart, R
Journal:
Annals of oncology
Issue:
Volume 29:Number 8(2018)
Page Start:
1658
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC). (25th October 2017)

Authors:
Bamias, A; Tzannis, K; Harshman, L C; Crabb, S J; Wong, Y -N; Kumar Pal, S; De Giorgi, U; Ladoire, S; Agarwal, N; Yu, E Y; Niegisch, G; Necchi, A; Sternberg, C N; Srinivas, S; Alva, A; Vaishampayan, U; Cerbone, L; Liontos, M; Rosenberg, J; Powles, T
Journal:
Annals of oncology
Issue:
Volume 29:Number 2(2018)
Page Start:
361
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

18. Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC). (13th August 2019)

Authors:
Bamias, A; Tzannis, K; Harshman, L C; Crabb, S J; Wong, Y -N; Kumar Pal, S; De Giorgi, U; Ladoire, S; Agarwal, N; Yu, E Y; Niegisch, G; Necchi, A; Sternberg, C N; Srinivas, S; Alva, A; Vaishampayan, U; Cerbone, L; Liontos, M; Rosenberg, J; Powles, T
Journal:
Annals of oncology
Issue:
Volume 30:Number 11(2019)
Page Start:
1841
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

19. Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up. (3rd May 2019)

Authors:
Fradet, Y; Bellmunt, J; Vaughn, D J; Lee, J L; Fong, L; Vogelzang, N J; Climent, M A; Petrylak, D P; Choueiri, T K; Necchi, A; Gerritsen, W; Gurney, H; Quinn, D I; Culine, S; Sternberg, C N; Nam, K; Frenkl, T L; Perini, R F; de Wit, R; Bajorin, D F
Journal:
Annals of oncology
Issue:
Volume 30:Number 6(2019)
Page Start:
970
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗